Mosunetuzumab for Follicular Lymphoma User Reviews
Brand names: Lunsumio
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Follicular Lymphoma
Care guides
More about mosunetuzumab
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Lunsumio (mosunetuzumab) "I've had 4 treatments, 1mg, 2mg, and 2 - 60mg. I've been extremely tired after the two 60mg treatments. Unable to stand without assistance for a few days after treatment. Could not read or comprehend my daily readings. After 12 days from my last treatment, I am just now beginning to be able to take walks and short hikes. I intend to take two more 30mg treatments and then stop so I can enjoy a two-week trip to Hawaii. Upon returning in mid-June, I will meet with my oncologist and the City of Hope doctors for further evaluation and treatment."